PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:41 AM ET

Sponsor Check › Person

PF
No photo found yet (own website and image search run after this page is viewed)

Philip Ferneau

Named as an officer, director or promoter on SEC Form D filings · NH, ME, MA · Mar 15, 2013 → May 4, 2023

13deals (issuers)
$697.8Mreported sold
343investors
44Form D filings
2013–2023years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Philip Ferneau is listed as an executive officer and director on 44 SEC Form D filings by 13 issuers between May 2009 and May 2023. Largest by amount reported sold: Direct Vet Marketing, Inc. (Portland, ME — industry reported as "Other" — 2010–2017; $223.5M reported sold to 33 investors), Compass Therapeutics, Inc. (Cambridge, MA — industry reported as "Other" — 2020; $195.3M reported sold to 114 investors), Compass Therapeutics LLC (Cambridge, MA — biotechnology — 2015–2018; $110.2M reported sold to 20 investors), Ankyra Therapeutics, Inc. (Boston, MA — biotechnology — 2021; $45M reported sold to 14 investors), AVEDRO INC (Waltham, MA — other health care — 2009–2015; $41.9M reported sold to 23 investors) and 8 more (all listed below).

What this means That is a lot of deals — 13 separate companies raised money with this person listed as executive officer and director, over about 14 years. Across those companies the filings report $697.8M sold in total.

Listed alongside Benjamin Shaw (12 shared filings), Anthony Natale (10 shared filings), David F. Muller (10 shared filings), Joseph Mandato (10 shared filings), M. Carl Johnson, III (10 shared filings) and 70 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Philip. Each name links to their own page.

The issuers belong to 2 sponsor groups: Compass Therapeutics (2 issuers, $170.7M reported sold, 2014–2020) and Borealis (4 issuers, $150.7M reported sold, 2017–2023).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 44 public filings for Philip Ferneau and found 17 differences, 1 worth asking the sponsor about: Philip Ferneau appears on 3 deals that stopped filing before reaching their target; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Philip Ferneau has not run yet — it is joining a line of 25,585 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Philip Ferneau..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

Gildner's Inc. v. Ferneau closed
United States Bankruptcy Court, S.D. Iowa · No. 94-94093 · Filed Sep 2, 1994 · Closed Dec 16, 1994
Role of Ferneau: Defendant · Outcome: Case closed 1994-12-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 2 federal dockets); surname only in the caption; court in IA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

17 differences found between the filings for Philip Ferneau — 1 worth asking about (compared 44 filings on Oct 24, 2026)

Note · Dec 16, 2002 – Nov 6, 2007

Bankruptcy case: William E End and Anita J End — filed Dec 16, 2002

United States Bankruptcy Court, C.D. California docket "William E End and Anita J End" filed Dec 16, 2002, closed Nov 6, 2007. William End (listed on the same filings) is listed as Debtor ("William E End and Anita J End"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗William End — PartnerFacts page ↗
Sources
Note · Sep 2, 1994 – Dec 16, 1994

Bankruptcy case: Gildner's Inc. v. Ferneau — filed Sep 2, 1994

United States Bankruptcy Court, S.D. Iowa docket "Gildner's Inc. v. Ferneau" filed Sep 2, 1994, closed Dec 16, 1994. Philip Ferneau is listed as Defendant ("Ferneau"). Our match estimate: 40%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, S.D. Iowa ↗
Sources
Note · Aug 24, 2018

11% of the money raised went to insiders — Avitide, Inc.

The Aug 24, 2018 Form D reports $6,212,290 sold and $672,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "Includes salary and bonuses payable in the ordinary course of business.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Aug 24, 2018 ↗Avitide, Inc. — PartnerFacts page ↗
Sources
Note · Jan 2, 2018

11% of the money raised went to insiders — Avitide, Inc.

The Jan 2, 2018 Form D reports $3,999,983 sold and $440,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate). Issuer's note: "Includes salary and bonuses payable in the ordinary course of business.".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Jan 2, 2018 ↗Avitide, Inc. — PartnerFacts page ↗
Sources
Worth asking · Mar 20, 2015 – May 4, 2023

Philip Ferneau appears on 3 deals that stopped filing before reaching their target

Borealis Fund VI, LP (last filing May 4, 2023; $5,290,000 sold of $100,000,000); Vox Health Fund, LP (last filing Jan 27, 2020; $12,050,000 sold of $50,000,000); BAR HARBOR BIOTECHNOLOGY INC (last filing Mar 20, 2015; $280,000 sold of $750,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Borealis Fund VI, LP — PartnerFacts page ↗Vox Health Fund, LP — PartnerFacts page ↗BAR HARBOR BIOTECHNOLOGY INC — PartnerFacts page ↗
Sources
Note · Dec 22, 2017 – Jan 8, 2018

Form D filed 17 days after the first sale — Compass Therapeutics LLC

The filing says the first sale was Dec 22, 2017. The Form D was filed Jan 8, 2018 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jan 8, 2018 ↗Compass Therapeutics LLC — PartnerFacts page ↗
Sources
Note · May 17, 2012 – Jun 12, 2012

Form D filed 26 days after the first sale — Direct Vet Marketing, Inc.

The filing says the first sale was May 17, 2012. The Form D was filed Jun 12, 2012 — 26 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 11 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jun 12, 2012 ↗Direct Vet Marketing, Inc. — PartnerFacts page ↗
Sources
Note · Jun 11, 2010 – Jul 1, 2010

Form D filed 20 days after the first sale — Direct Vet Marketing, Inc.

The filing says the first sale was Jun 11, 2010. The Form D was filed Jul 1, 2010 — 20 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 5 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jul 1, 2010 ↗Direct Vet Marketing, Inc. — PartnerFacts page ↗
Sources
Note · Jun 11, 2010 – May 4, 2023

15 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Borealis Fund VI, LP (latest filing May 4, 2023) · No amendment in the last 12 months on an offering that may still be open — Borealis Fund V - Veterinary Innovation, LP (latest filing Sep 20, 2022) · No amendment in the last 12 months on an offering that may still be open — Compass Therapeutics, Inc. (latest filing Jul 1, 2020) · No amendment in the last 12 months on an offering that may still be open — Vox Health Fund, LP (latest filing Jan 27, 2020) · No amendment in the last 12 months on an offering that may still be open — Compass Therapeutics LLC (latest filing Jul 16, 2018) · and 10 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · May 4, 2023 ↗Borealis Fund VI, LP — PartnerFacts page ↗Form D/A · Sep 20, 2022 ↗Borealis Fund V - Veterinary Innovation, LP — PartnerFacts page ↗
Sources
Note · Jul 1, 2010 – Sep 21, 2016

6 offerings changed their target amount between filings

Offering amount changed between filings — Compass Therapeutics LLC · Offering amount changed between filings — AVEDRO INC · Offering amount changed between filings — AVEDRO INC · Offering amount changed between filings — Direct Vet Marketing, Inc. · Offering amount changed between filings — AVEDRO INC · and 1 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Jul 1, 2015 ↗Form D/A (later) · Sep 21, 2016 ↗Compass Therapeutics LLC — PartnerFacts page ↗Form D (earlier) · Nov 19, 2014 ↗
Sources
Note · May 11, 2009 – Jul 1, 2010

Philip Ferneau is written 2 different ways on the filings

listed as "Philip J. Ferneau" on 13 filings (from May 11, 2009), and "Philip Ferneau" on 31 filings (from Jul 1, 2010).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · May 11, 2009 ↗Form D · Jul 1, 2010 ↗Philip Ferneau — PartnerFacts page ↗
Sources
Note · Mar 15, 2013 – Oct 23, 2019

Industry group changed between filings — Avitide, Inc.

"Biotechnology" (Mar 15, 2013 to Aug 6, 2015); then "Pharmaceuticals" (Jun 27, 2017 to Aug 24, 2018); then "Biotechnology" (Oct 23, 2019).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Mar 15, 2013 ↗Form D · Jun 27, 2017 ↗Form D · Oct 23, 2019 ↗Avitide, Inc. — PartnerFacts page ↗
Sources
Note · Jul 1, 2010 – Jul 24, 2017

Industry group changed between filings — Direct Vet Marketing, Inc.

"Retailing" (Jul 1, 2010 to Jun 12, 2012); then "Other Health Care" (Jun 12, 2013 to Jul 17, 2015); then "Other" (Jul 24, 2017).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jul 1, 2010 ↗Form D · Jun 12, 2013 ↗Form D · Jul 24, 2017 ↗Direct Vet Marketing, Inc. — PartnerFacts page ↗
Sources
Note · Jul 1, 2015 – Sep 21, 2016

Address moved from Hanover, NH to Cambridge, MA — Compass Therapeutics LLC

The people listed on the Jul 1, 2015 filing give Hanover, NH; on the Sep 21, 2016 filing they give Cambridge, MA. The address now on file (245 First Street, Cambridge, MA) is a registered-agent or shared-office address used by 7 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Jul 1, 2015 ↗Form D/A · Sep 21, 2016 ↗Compass Therapeutics LLC — PartnerFacts page ↗
Sources
Note · Jul 16, 2015 – Jul 17, 2015

Address moved from Portland, MA to Portland, ME — Direct Vet Marketing, Inc.

The people listed on the Jul 16, 2015 filing give Portland, MA; on the Jul 17, 2015 filing they give Portland, ME.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 16, 2015 ↗Form D/A · Jul 17, 2015 ↗Direct Vet Marketing, Inc. — PartnerFacts page ↗
Sources
Note · Mar 20, 2015 – Jul 16, 2015

Address moved from Portland, ME to Portland, MA — Direct Vet Marketing, Inc.

The people listed on the Mar 20, 2015 filing give Portland, ME; on the Jul 16, 2015 filing they give Portland, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Mar 20, 2015 ↗Form D · Jul 16, 2015 ↗Direct Vet Marketing, Inc. — PartnerFacts page ↗
Sources
Note · May 11, 2009 – May 4, 2023

Philip Ferneau is listed with 3 different address states: NH, ME, MA

NH on 26 filings (May 11, 2009 to May 4, 2023); ME on 9 filings (Jul 1, 2010 to Jul 24, 2017); MA on 9 filings (Jul 16, 2015 to Dec 23, 2022).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · May 11, 2009 ↗Form D · Jul 1, 2010 ↗Form D · Jul 16, 2015 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 32 offerings reports sales commissions totalling $4,700,000; 1 reports finder's fees totalling $478,125; 4 report proceeds to related persons totalling $3,504,460. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
May 4, 2023 D/A
Borealis Fund VI, LP
File 021-444364
$0$0$0 (est.)
An affiliate of the General Partner will receive an annual management fee, payable by the Issuer as set forth in the governing documents of the Issuer.
None listed on this filingEDGAR ↗
Dec 23, 2022 D
Amagma, Inc.
File 021-468628
$0$0$0None listed on this filingEDGAR ↗
Sep 20, 2022 D/A
Borealis Fund V - Veterinary Innovation, LP
File 021-414015
$0$0$0 (est.)
An affiliate of the General Partner will receive an annual management fee, payable by the Issuer as set forth in the governing documents of the Issuer.
None listed on this filingEDGAR ↗
Jun 1, 2022 D
Amagma, Inc.
File 021-447704
$0$0$0None listed on this filingEDGAR ↗
Sep 9, 2021 D
Ankyra Therapeutics, Inc.
File 021-412827
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2020 D
Compass Therapeutics, Inc.
File 021-370112
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2020 D
Compass Therapeutics, Inc.
File 021-370115
$4,700,000$0$0Raymond James & Associates, Inc. BrokerCheck CRD 705 ↗
B. Riley FBR, Inc. BrokerCheck CRD 25027 ↗
Katalyst Securities LLC BrokerCheck CRD 112494 ↗		EDGAR ↗
Jan 27, 2020 D/A
Vox Health Fund, LP
File 021-292572
$0$0$0 (est.)
An affiliate of the General Partner will receive an annual management fee, payable by the Issuer as set forth in the governing documents of the Issuer.
None listed on this filingEDGAR ↗
Oct 23, 2019 D
Avitide, Inc.
File 021-351722
$0$0$0None listed on this filingEDGAR ↗
Aug 24, 2018 D
Avitide, Inc.
File 021-319991
$0$0$672,000 (est.)
Includes salary and bonuses payable in the ordinary course of business.
None listed on this filingEDGAR ↗
Jul 16, 2018 D/A
Compass Therapeutics LLC
File 021-242888
$0$0$1,710,000 (est.)None listed on this filingEDGAR ↗
Jan 8, 2018 D
Compass Therapeutics LLC
File 021-302629
$0$0$0None listed on this filingEDGAR ↗
Jan 2, 2018 D
Avitide, Inc.
File 021-302123
$0$0$440,000 (est.)
Includes salary and bonuses payable in the ordinary course of business.
None listed on this filingEDGAR ↗
Jul 24, 2017 D
Direct Vet Marketing, Inc.
File 021-291350
$0$0$0None listed on this filingEDGAR ↗
Jun 27, 2017 D
Avitide, Inc.
File 021-289476
$0$0$682,460 (est.)
Includes salary and bonuses payable in the ordinary course of business.
None listed on this filingEDGAR ↗
Nov 25, 2015 D
AVEDRO INC
File 021-251933
$0$0$0None listed on this filingEDGAR ↗
Aug 6, 2015 D
Avitide, Inc.
File 021-245207
$0$0$0None listed on this filingEDGAR ↗
Jul 17, 2015 D/A
Direct Vet Marketing, Inc.
File 021-243842
$0$0$0None listed on this filingEDGAR ↗
Apr 7, 2015 D/A
AVEDRO INC
File 021-228625
$0$0$0None listed on this filingEDGAR ↗
Mar 20, 2015 D
Direct Vet Marketing, Inc.
File 021-236325
$0$0$0None listed on this filingEDGAR ↗
Jun 9, 2014 D
Avitide, Inc.
File 021-218775
$0$0$0None listed on this filingEDGAR ↗
Jun 12, 2013 D
Direct Vet Marketing, Inc.
File 021-197865
$0$0$0None listed on this filingEDGAR ↗
Mar 15, 2013 D
Avitide, Inc.
File 021-193359
$0$0$0None listed on this filingEDGAR ↗
Mar 12, 2013 D
AVEDRO INC
File 021-193139
$0$0$0None listed on this filingEDGAR ↗
Jun 12, 2012 D
Direct Vet Marketing, Inc.
File 021-179572
$0$0$0None listed on this filingEDGAR ↗
Feb 17, 2012 D/A
AVEDRO INC
File 021-162873
$0$478,125$0BMO Caital Markets Corp. BrokerCheck CRD 16686 ↗
via BMO Capital Markets Corp. (CRD 16686 ↗)
EDGAR ↗
May 20, 2011 D/A
Direct Vet Marketing, Inc.
File 021-144314
$0$0$0None listed on this filingEDGAR ↗
May 20, 2011 D
BAR HARBOR BIOTECHNOLOGY INC
File 021-160144
$0$0$0None listed on this filingEDGAR ↗
May 9, 2011 D/A
AVEDRO INC
File 021-145662
$0$0$0None listed on this filingEDGAR ↗
Oct 7, 2010 D
Pooled Clinical Data Partners, Inc.
File 021-148704
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2010 D
FETCH ENTERPRISES INC
File 021-144311
$0$0$0None listed on this filingEDGAR ↗
May 11, 2009 D
AVEDRO INC
File 021-82758
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 13

Every issuer that named Philip Ferneau on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

BF
Pooled Investment Fund · group: Borealis

Borealis Fund VI, LP

Hanover, NH · May 4, 2022 → May 4, 2023 · 2 filings
  • May 4, 2023 · D/A · $5,290,000 sold of $100,000,000 · 16 investors · min. No minimum reported · role: Executive Officer (Member of the Issuer's General Partner) EDGAR ↗
  • May 4, 2022 · D · $0 sold of $100,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Member of the Issuer's General Partner) EDGAR ↗

Raised $5.29M from 16 investors (5% of the $100M target) as of the latest filing. Philip is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Biotechnology

Amagma, Inc.

Waltham, MA · Jun 1, 2022 → Dec 23, 2022 · 2 filings
  • Dec 23, 2022 · D · $10,000,000 sold of $10,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 1, 2022 · D · $2,275,888 sold of $2,275,888 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $16.4M from 14 investors (100% of the $10M target) as of the latest filing. Philip is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BF
Pooled Investment Fund · group: Borealis

Borealis Fund V - Veterinary Innovation, LP

Hanover, NH · Sep 21, 2021 → Sep 20, 2022 · 2 filings
  • Sep 20, 2022 · D/A · $33,590,000 sold of $50,000,000 · 55 investors · min. No minimum reported · role: Executive Officer (Manager of the Issuer's General Partner) EDGAR ↗
  • Sep 21, 2021 · D · $0 sold of $50,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Manager of the Issuer's General Partner) EDGAR ↗

Raised $33.6M from 55 investors (67% of the $50M target) as of the latest filing. Philip is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Biotechnology

Ankyra Therapeutics, Inc.

Boston, MA · Sep 9, 2021
  • Sep 9, 2021 · D · $44,999,979 sold of $44,999,979 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $45M from 14 investors (100% of the $45M target) as of the latest filing. Philip is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Other · group: Compass Therapeutics

Compass Therapeutics, Inc.

Cambridge, MA · Jul 1, 2020 → Jul 1, 2020 · 2 filings
  • Jul 1, 2020 · D · $60,482,210 sold of $70,000,000 · 110 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2020 · D · $195,276,780 sold of $195,276,780 · 114 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $195.3M from 114 investors (100% of the $70M target) as of the latest filing. Philip is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VH
Pooled Investment Fund

Vox Health Fund, LP

Hanover, NH · Aug 10, 2017 → Jan 27, 2020 · 3 filings
  • Jan 27, 2020 · D/A · $12,050,000 sold of $50,000,000 · 21 investors · min. No minimum reported · role: Executive Officer (Manager of the Issuer's General Partner) EDGAR ↗
  • Aug 7, 2018 · D/A · $11,550,000 sold of $50,000,000 · 18 investors · min. No minimum reported · role: Executive Officer (Manager of the Issuer's General Partner) EDGAR ↗
  • Aug 10, 2017 · D · $0 sold of $50,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Manager of the Issuer's General Partner) EDGAR ↗

Raised $12.1M from 21 investors (24% of the $50M target) as of the latest filing. Philip is listed as executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Biotechnology

Avitide, Inc.

Lebanon, NH · Mar 15, 2013 → Oct 23, 2019 · 7 filings
  • Oct 23, 2019 · D · $9,999,796 sold of $9,999,796 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 24, 2018 · D · $6,212,290 sold of $6,212,290 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 2, 2018 · D · $3,999,983 sold of $3,999,983 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 27, 2017 · D · $11,999,962 sold of $11,999,962 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 6, 2015 · D · $3,831,920 sold of $7,663,840 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 9, 2014 · D · $3,435,003 sold of $3,435,003 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 15, 2013 · D · $1,449,999 sold of $1,449,999 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $12M from 11 investors (100% of the $10M target) as of the latest filing. Philip is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Biotechnology · group: Compass Therapeutics

Compass Therapeutics LLC

Cambridge, MA · Jul 1, 2015 → Jul 16, 2018 · 4 filings
  • Jul 16, 2018 · D/A · $110,191,606 sold of $170,205,999 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 8, 2018 · D · $21,847,787 sold of $49,999,999 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 21, 2016 · D/A · $45,977,738 sold of $170,205,999 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2015 · D · $15,977,535 sold of $120,977,535 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $110.2M from 20 investors (65% of the $170.2M target) as of the latest filing. Philip is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

DV
Other

Direct Vet Marketing, Inc.

Portland, ME · Jul 1, 2010 → Jul 24, 2017 · 8 filings
  • Jul 24, 2017 · D · $223,549,994 sold of $223,549,994 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 17, 2015 · D/A · $52,301,142 sold of $52,301,142 · 33 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 16, 2015 · D · $52,301,142 sold of $52,301,142 · 33 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 20, 2015 · D · $5,202,000 sold of $5,202,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 12, 2013 · D · $6,588,540 sold of $6,588,540 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 12, 2012 · D · $3,000,000 sold of $3,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 20, 2011 · D/A · $2,006,034 sold of $3,306,034 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 1, 2010 · D · $1,149,522 sold of $2,006,034 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $223.5M from 33 investors (100% of the $223.5M target) as of the latest filing. Philip is listed as director on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Other Health Care

AVEDRO INC

Waltham, MA · May 11, 2009 → Nov 25, 2015 · 10 filings
  • Nov 25, 2015 · D · $16,533,010 sold of $32,000,000 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 7, 2015 · D/A · $13,693,602 sold of $17,555,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 19, 2014 · D · $6,500,000 sold of $13,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 12, 2013 · D · $41,875,000 sold of $42,875,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 17, 2012 · D/A · $26,031,735 sold of $26,031,735 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 14, 2011 · D · $25,531,735 sold of $25,531,735 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 9, 2011 · D/A · $13,267,466 sold of $15,500,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 5, 2011 · D/A · $6,295,475 sold of $8,000,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 29, 2010 · D · $4,580,475 sold of $5,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 11, 2009 · D · $10,000,002 sold of $10,000,002 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $41.9M from 23 investors (100% of the $32M target) as of the latest filing. Philip is listed as director on 10 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BH
Biotechnology

BAR HARBOR BIOTECHNOLOGY INC

Trenton, ME · May 20, 2011
  • May 20, 2011 · D · $280,000 sold of $750,000 · 2 investors · min. $30,000 · role: Director EDGAR ↗

Raised $280K from 3 investors (37% of the $750K target) as of the latest filing. Philip is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

PC
Other

Pooled Clinical Data Partners, Inc.

Lebanon, NH · Oct 7, 2010
  • Oct 7, 2010 · D · $1,428,000 sold of $2,428,000 · 13 investors · min. $7,000 · role: Director EDGAR ↗

Raised $1.43M from 13 investors (59% of the $2.43M target) as of the latest filing. Philip is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

FE
Retailing

FETCH ENTERPRISES INC

Portland, ME · Jul 1, 2010
  • Jul 1, 2010 · D · $933,907 sold of $1,500,001 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $934K from 6 investors (62% of the $1.5M target) as of the latest filing. Philip is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Philip 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

BC
Management entity

Borealis Capital Partners IV, LLC

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

BC
Management entity

Borealis Capital Partners V, LLC

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

BC
Management entity

Borealis Capital Partners VI, LLC

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Benjamin Shaw

Executive Officer, Director · 12 shared filings (3 issuers) · also on 3 other issuers

Benjamin Shaw is on 6 issuers in total — a repeat sponsor. Their page lists every one.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Natale

Director · 10 shared filings (1 issuer) · also on 11 other issuers

Anthony Natale is on 12 issuers in total — a repeat sponsor. Their page lists every one.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Mandato

Director · 10 shared filings (1 issuer) · also on 4 other issuers

Joseph Mandato is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MJ
No photo found yet (own website and image search run after this page is viewed)
Person

M. Carl Johnson, III

Director · 10 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

David F. Muller

Executive Officer, Director · 10 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

TG
No photo found yet (own website and image search run after this page is viewed)
Person

Tillman U. Gerngross

Executive Officer, Director · 9 shared filings (3 issuers) · also on 5 other issuers

Tillman U. Gerngross is on 8 issuers in total — a repeat sponsor. Their page lists every one.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

DAVID SHAW

Director · 9 shared filings (2 issuers) · also on 6 other issuers

DAVID SHAW is on 8 issuers in total — a repeat sponsor. Their page lists every one.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Rhonda J. Bracey

Executive Officer · 8 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Doug Cole

Director · 7 shared filings (1 issuer) · also on 4 other issuers

Doug Cole is on 5 issuers in total — a repeat sponsor. Their page lists every one.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 6 shared filings (2 issuers) · also on 60 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

EA
No photo found yet (own website and image search run after this page is viewed)
Person

Errik Anderson

Director, Executive Officer, Promoter · 6 shared filings (2 issuers) · also on 15 other issuers

Errik Anderson is on 17 issuers in total — a repeat sponsor. Their page lists every one.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas J. Schuetz

Executive Officer, Director, Promoter · 6 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jeff Dykan

Director · 6 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

KI
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Isett

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

RG
No photo found yet (own website and image search run after this page is viewed)
Person

Rishi Gupta

Director · 6 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

EDWARD M MCNAMARA

Director · 5 shared filings (1 issuer) · also on 6 other issuers

EDWARD M MCNAMARA is on 7 issuers in total — a repeat sponsor. Their page lists every one.

WK
No photo found yet (own website and image search run after this page is viewed)
Person

Warren Kett

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

CN
No photo found yet (own website and image search run after this page is viewed)
Person

Claudio Nessi

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Bitterman

Director · 4 shared filings (1 issuer) · also on 23 other issuers

Kevin Bitterman is on 24 issuers in total — a repeat sponsor. Their page lists every one.

BA
No photo found yet (own website and image search run after this page is viewed)
Person

Ben Auspitz

Director · 4 shared filings (1 issuer) · also on 5 other issuers

Ben Auspitz is on 6 issuers in total — a repeat sponsor. Their page lists every one.

YC
No photo found yet (own website and image search run after this page is viewed)
Person

YUMIN CHOI

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Squinto

Director · 4 shared filings (2 issuers) · also on 14 other issuers

Stephen Squinto is on 16 issuers in total — a repeat sponsor. Their page lists every one.

IR
No photo found yet (own website and image search run after this page is viewed)
Person

Ian Ratcliffe

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Kennedy

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

VL
No photo found yet (own website and image search run after this page is viewed)
Person

VERED BISKER-LEIB

Executive Officer · 4 shared filings (2 issuers)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Ross

Director · 4 shared filings (1 issuer) · also on 29 other issuers

Michael Ross is on 30 issuers in total — a repeat sponsor. Their page lists every one.

ST
No photo found yet (own website and image search run after this page is viewed)
Person

STEVE TREGAY

Director · 4 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Bergkamp

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

AJAY ROYAN

Director · 3 shared filings (2 issuers) · also on 3 other issuers

AJAY ROYAN is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Palmisano

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Jason Hong

Director · 3 shared filings (1 issuer) · also on 6 other issuers

Jason Hong is on 7 issuers in total — a repeat sponsor. Their page lists every one.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Amy Schulman

Director · 2 shared filings (1 issuer) · also on 19 other issuers

Amy Schulman is on 20 issuers in total — a repeat sponsor. Their page lists every one.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Bigham

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

David Berry

Director · 2 shared filings (1 issuer) · also on 13 other issuers

David Berry is on 14 issuers in total — a repeat sponsor. Their page lists every one.

KM
No photo found yet (own website and image search run after this page is viewed)
Person

Kerry Muse

Director · 2 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

BR
No photo found yet (own website and image search run after this page is viewed)
Person

Brian J. Roberts

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Philip Ferneau. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Ravi Sachdev

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Ravi Sachdev is on 5 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

CT
Sponsor group

Compass Therapeutics

2 issuers · 8 filings · $170.7M reported sold · 2014–2020

One team, 2 deal companies. Philip Ferneau is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Philip Ferneau.

B
Sponsor group

Borealis

4 issuers · 8 filings · $150.7M reported sold · 2017–2023

One team, 4 deal companies. Philip Ferneau is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Philip Ferneau.

Same business address

30 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 13 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Philip Ferneau by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 13 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Philip Ferneau is listed on: none on file. No website or social profile named in Compass Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #212,953 of 374,652 in line (1,298 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Hampshire state courts — find the court ↗Maine state courts — find the court ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Hampshire Secretary of State business search ↗Maine Secretary of State business search ↗Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Philip Ferneau appears on a new Form D, or when a court case or SEC action is matched to them. See plans →